Skip to main content

Advertisement

Table 3 Distribution of types of recommendation, by implementation group

From: Which factors affect the implementation of geriatric recommendations by primary care physicians?

  Q1- Implementation 0–24% (N = 124) Q2- Implementation 25–49% (N = 103) Q3- Implementation 50–74% (N = 143) Q4- Implementation 75–100% (N = 118) All (N = 488) P* P **
  Mean ± SD Range N Mean ± SD Range N Mean ± SD Range N Mean ± SD Range N Mean ± SD Range N
Add/increase dose of drug 2.0 ± 1.0 1–5 97 1.9 ± 1.0 1–5 87 2.1 ± 1.2 1–5 111 1.9 ± 1.1 1–5 94 2.0 ± 1.1 1–5 389 0.65 0.44
Stop/decrease dose of drug 2.3 ± 1.5 1–7 74 2.1 ± 1.3 1–7 58 2.3 ± 1.5 1–7 90 2.0 ± 1.4 1–6 68 2.2 ± 1.5 1–7 290 0.86 0.98
All pharmacologic recommendations 3.3 ± 1.8 1–9 110 2.9 ± 1.75 1–9 96 3.2 ± 2.1 1–10 137 3.2 ± 1.9 1–9 103 3.2 ± 1.9 1–10 446 0.63 0.76
Laboratory tests 2.1 ± 1.2 1–6 52 1.7 ± 1.1 1–7 53 2.3 ± 1.3 1–5 62 2.0 ± 1.2 1–7 63 2.0 ± 1.2 1–7 230 0.08 0.78
Imaging and other diagnostic tests 1.4 ± 0.6 1–4 73 1.4 ± 0.7 1–4 61 1.5 ± 0.8 1–5 71 1.6 ± 0.7 1–3 50 1.5 ± 0.7 1–5 255 0.61 0.15
“MD” referral 1.5 ± 0.7 1–1 56 1.5 ± 0.6 1–3 63 1.6 ± 0.9 1–4 63 1.4 ± 0.7 1–3 45 1.5 ± 0.7 1–4 207 0.44 0.52
“Non-MD” referral 1.4 ± 0.6 1–1 90 1.4 ± 0.5 1–2 64 1.3 ± 0.5 1–3 90 1.3 ± 0.5 1–3 71 1.4 ± 0.5 1–4 315 0.53 0.42
Immunization 1.9 ± 0.8 1–3 62 1.9 ± 0.8 1–3 60 1.8 ± 0.8 1–3 77 1.4 ± 0.5 1–3 53 1.8 ± 0.8 1–3 252 0.019 0.002
Total 7.2 ± 3.5 1–17 124 7.1 ± 3.3 3–18 103 7.3 ± 3.7 2–18 143 6.5 ± 3.6 1–15 118 7.0 ± 3.6 1–18 488 0.27 0.11
  1. P* among all Q groups, P** between Q1/Q4